Clinical Trial Update: Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating mecapegfilgrastim combined with adebrelimab and chemotherapy as neoadjuvant therapy for resectable gastric cancer and gas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Mecapegfilgrastim

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: GC/GEJC | Phase 2 | Status: NOT_YET_RECRUITING